BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16879691)

  • 1. Effects of intravesical instillation of cyclooxygenase-2 inhibitor on the expression of inducible nitric oxide synthase and nerve growth factor in cyclophosphamide-induced overactive bladder.
    Jang J; Park EY; Seo SI; Hwang TK; Kim JC
    BJU Int; 2006 Aug; 98(2):435-9. PubMed ID: 16879691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.
    Chuang YC; Yoshimura N; Huang CC; Wu M; Chiang PH; Chancellor MB
    Eur Urol; 2009 Jul; 56(1):159-66. PubMed ID: 18514386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.
    Dudhgaonkar SP; Tandan SK; Kumar D; Raviprakash V; Kataria M
    Inflammopharmacology; 2007 Oct; 15(5):188-95. PubMed ID: 17943250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder instillation of Escherichia coli lipopolysaccharide alters the muscle contractions in rat urinary bladder via a protein kinase C-related pathway.
    Weng TI; Chen WJ; Liu SH
    Toxicol Appl Pharmacol; 2005 Oct; 208(2):163-9. PubMed ID: 16183390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of interleukin-6-regulated nitric oxide synthase in hemorrhagic cystitis and impaired bladder contractions in young rats induced by acrolein, a urinary metabolite of cyclophosphamide.
    Wang CC; Weng TI; Wu ET; Wu MH; Yang RS; Liu SH
    Toxicol Sci; 2013 Jan; 131(1):302-10. PubMed ID: 22961095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder.
    Juszczak K; Ziomber A; Wyczółkowski M; Thor PJ
    Can J Physiol Pharmacol; 2010 Sep; 88(9):899-906. PubMed ID: 20921976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats.
    Juszczak K; Ziomber A; Wyczolkowski M; Thor PJ
    J Physiol Pharmacol; 2009 Dec; 60(4):85-91. PubMed ID: 20065501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis.
    Ho DR; Chen CS; Lin WY; Chang PJ; Huang YC
    Int J Urol; 2011 Jul; 18(7):525-31. PubMed ID: 21605172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.
    Kuo HC; Liu HT; Chancellor MB
    Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide induced cystitis: role of nitric oxide synthase, cyclooxygenase-1 and 2, and NK(1) receptors.
    Linares-Fernández BE; Alfieri AB
    J Urol; 2007 Apr; 177(4):1531-6. PubMed ID: 17382773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder instillation and intraperitoneal injection of Escherichia coli lipopolysaccharide up-regulate cytokines and iNOS in rat urinary bladder.
    Olsson LE; Wheeler MA; Sessa WC; Weiss RM
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1203-8. PubMed ID: 9495884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-deoxy-Delta12,14-prostaglandin J2 attenuates development of cyclophosphamide-induced cystitis in rats.
    Masuda H; Chancellor MB; Kihara K; Yoshimura N
    Urology; 2006 Feb; 67(2):435-9. PubMed ID: 16461118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats.
    Sakura M; Masuda H; Matsuoka Y; Yokoyama M; Kawakami S; Kihara K
    BJU Int; 2009 Jan; 103(2):264-9. PubMed ID: 18710439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-1 suppresses lipopolysaccharide-induced changes in rat gastric inducible nitric oxide synthase.
    West SD; Suliburk JW; Helmer KS; Mercer DW
    Crit Care Med; 2008 Feb; 36(2):572-9. PubMed ID: 18216606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phosphodiesterase type 4 inhibitor rolipram on cyclophosphamide-induced cystitis in rats.
    Büyüknacar HS; Kumcu EK; Göçmen C; Onder S
    Eur J Pharmacol; 2008 May; 586(1-3):293-9. PubMed ID: 18358472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.
    Kim JC; Park EY; Hong SH; Seo SI; Park YH; Hwang TK
    Int J Urol; 2005 Oct; 12(10):875-80. PubMed ID: 16323980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
    Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
    Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
    Liu HT; Kuo HC
    Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nitric oxide synthases on detrusor overactivity after removal of bladder outlet obstruction in rats.
    Kim HS; Kim JC; Choo MS
    Urol Int; 2008; 81(1):107-12. PubMed ID: 18645281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.